Possible anti-aging drug
Scientists have discovered a new method of enhancing the activity of a protein that can dramatically extend lifespan, opening up the possibility of a new 'anti-aging' drug.
Archives for February 12, 2007
SCOLR drops phenylephrine plans
US firm SCOLR Pharma has dropped development plans for a controlled release phenylephrine (PE) formulation, in light of slow progress in the over-the-counter (OTC) PE market.
Genetic test for Type II diabetes moves closer
Scientists have mapped the most important genes associated with the risk of developing Type II diabetes, bringing a genetic test to identify those most at risk a step closer.
Irish plants latest casualty as Pfizer trims API manufacturing
Heavyweight Pfizer is the latest pharmaceutical to cut manufacturing capacity and shut down plants as it announces the closure and sale of active pharmaceutical ingredient (API) facilities in Ireland.
Dental implant keeps tabs on drug intake
European scientists have introduced a dental prosthesis capable of dosing drugs, which they suggest could be a more convenient option than swallowing pills.
Antibody therapy for psoriasis
A Phase II study has demonstrated the efficacy of an interleukin-12/23 monoclonal antibody in psoriasis.
Start-up to form early-phase umbrella group
A new start up company in the UK has been formed with ambitions to shape itself into a global early-phase drug development services group through an acquisition-based strategy.